Short-term foot complications in Charcot neuroarthropathy: A retrospective study in tertiary care centres in Spain

Endocrinologia, Diabetes y Nutricion - Tập 65 - Trang 479-485 - 2018
Montserrat Doria1,2, Jordi Viadé1, Elisabet Palomera3, Ricard Pérez4, Melcior Lladó5, Elisabet Costa6, Teresa Huguet7, Jordi Lluís Reverter1, Mateu Serra-Prat3, Josep Franch-Nadal8,9,10, Dídac Mauricio1,8,9,11
1Department of Endocrinology and Nutrition, University Hospital & Health Sciences Research Institute Germans Trias i Pujol, Badalona, Spain
2Diabetic Foot Unit, University Hospital Arnau de Vilanova, Lleida, Spain
3Epidemiology Service, Hospital de Mataró, Mataró, Spain
4Department of Radiology, University Hospital Germans Trias i Pujol, Badalona, Spain
5Diabetic Foot Unit, University Hospital Son Espases, Palma de Mallorca, Spain
6Department of Endocrinology and Nutrition, University Hospital Josep Trueta, Girona, Spain
7Diabetic Foot Unit, University Hospital Mutua, Terrassa, Spain
8Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain
9CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Spain
10Primary Health Care Center Raval Sud, Gerència d’Atenció Primaria, Institut Català de la Salut, Barcelona, Spain
11Department of Endocrinology & Nutrition, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain

Tài liệu tham khảo

Jeffcoate, 2005, The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes, Lancet, 366, 2058, 10.1016/S0140-6736(05)67029-8 Uccioli, 2010, Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot, Diabetes Care, 33, 350, 10.2337/dc09-1141 Rogers, 2011, The Charcot foot in diabetes, Diabetes Care, 34, 2123, 10.2337/dc11-0844 Fabrin, 2000, Long-term follow-up in diabetic Charcot feet with spontaneous onset, Diabetes Care, 23, 796, 10.2337/diacare.23.6.796 Rajbhandari, 2002, Charcot neuroarthropathy in diabetes mellitus, Diabetologia, 45, 1085, 10.1007/s00125-002-0885-7 Armstrong, 2002, Charcot's arthropathy of the foot, J Am Podiatr Med Assoc, 92, 390, 10.7547/87507315-92-7-390 Sanders, 2004, The Charcot foot: historical perspective 1827–2003, Diabetes Metab Res Rev, 20, S4, 10.1002/dmrr.451 Gouveri, 2011, Charcot osteoarthropathy in diabetes: a brief review with an emphasis on clinical practice, World J Diabetes, 2, 59, 10.4239/wjd.v2.i5.59 Armstrong, 2001, Charcot's arthropathy of the foot, Int Diabetes Monit, 13, 1 Cofield, 1983, Diabetic neuroarthropathy in the foot: patient characteristics and patterns of radiographic change, Foot Ankle, 4, 15, 10.1177/107110078300400104 Cavanagh, 1994, Radiographic abnormalities in the feet of patients with diabetic neuropathy, Diabetes Care, 17, 201, 10.2337/diacare.17.3.201 Petrova, 2008, Charcot neuro-osteoarthropathy-current standards, Diabetes Metab Res Rev, 24, S58, 10.1002/dmrr.846 Lee, 2003, Charcot joint disease in diabetes mellitus, Ann Vasc Surg, 17, 571, 10.1007/s10016-003-0039-5 Frykberg, 2008, Epidemiology of the Charcot foot, Clin Podiatr Med Surg, 25, 17, 10.1016/j.cpm.2007.10.001 Jeffcoate, 2015, Charcot foot syndrome, Diabet Med, 32, 760, 10.1111/dme.12754 La Fontaine, 2016, Current concepts of Charcot foot in diabetic patients, Foot, 26, 7, 10.1016/j.foot.2015.11.001 Frykberg, 2000, Management of the diabetic Charcot foot, Diabetes Metab Res Rev, 16, S59, 10.1002/1520-7560(200009/10)16:1+<::AID-DMRR134>3.0.CO;2-N Milne, 2013, Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot neuro-arthropathy: a systematic review, J Foot Ankle Res, 6, 30, 10.1186/1757-1146-6-30 Trieb, 2016, The Charcot foot: pathophysiology, diagnosis and classification, Bone Joint J, 98, 1155, 10.1302/0301-620X.98B9.37038 Gazis, 2004, Mortality in patients with diabetic neuropathic osteoarthropathy (Charcot foot), Diabet Med, 21, 1243, 10.1111/j.1464-5491.2004.01215.x Sohn, 2009, Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone, Diabetes Care, 32, 816, 10.2337/dc08-1695 van Baal, 2010, Mortality associated with acute Charcot foot and neuropathic foot ulceration, Diabetes Care, 33, 1086, 10.2337/dc09-1428 Bergis, 2014, Coronary artery disease as an independent predictor of survival in patients with type 2 diabetes and Charcot neuro-osteoarthropathy, Acta Diabetol, 51, 1041, 10.1007/s00592-014-0669-9 Pitocco, 2014, Atherosclerotic coronary plaque in subjects with diabetic neuropathy: the prognostic cardiovascular role of Charcot neuroarthropathy – a case–control study, Acta Diabetol, 51, 587 Schaper, 2016, Prevention and management of foot problems in diabetes: a Summary Guidance for Daily Practice 2015, based on the IWGDF Guidance Documents, Diabetes Metab Res Rev, 32, 7, 10.1002/dmrr.2695 Wukich, 2016, Prevalence of peripheral arterial disease in patients with diabetic Charcot neuroarthropathy, J Foot Ankle Surg, 55, 727, 10.1053/j.jfas.2016.01.051 Sohn, 2010, Lower-extremity amputation risk after Charcot arthropathy and diabetic foot ulcer, Diabetes Care, 33, 98, 10.2337/dc09-1497 Game, 2012, Audit of acute Charcot's disease in the UK: the CDUK study, Diabetologia, 55, 32, 10.1007/s00125-011-2354-7 Samann, 2012, Diabetic nephropathy but not HbA1c is predictive for frequent complications of Charcot feet – long-term follow-up of 164 consecutive patients with 195 acute Charcot feet, Exp Clin Endocrinol Diabetes, 120, 335, 10.1055/s-0031-1299705 McEwen, 2016, Foot complications and mortality: results from Translating Research Into Action for Diabetes (TRIAD), J Am Podiatr Med Assoc, 106, 7, 10.7547/14-115